Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Mark Terry, BioSpace.com… Source: BioSpace You Might Also Like Pfizer, Arvinas Forge $830M Protein Degradation R&D Deal January 3, 2018 Genentech's Top Cancer Prospect Flunks Phase III Test May 9, 2017 Johnson & Johnson Dissolves $700 Million R&D Deal With MacroGenics August 31, 2017
